Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 8-K Event Regulation FD disclosure
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Executive or director change
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 10-Q Report Quarterly Report
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Shareholder vote results
  18. 8-K Event Executive or director change
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 1 of 77 · 1,525 filings